Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1Dermatologic 1Classical hematology 1

Conditions

Tobacco Use Disorder 1Mouth Neoplasms 1Lichen Planus 1Leukokeratosis, Hereditary Mucosal 1Fanconi Anemia 1Erythroplasia 1

Interventions

Cyclophosphamide 8Whole-Body Irradiation 6fludarabine 5fludarabine phosphate 4Tacrolimus 4Mycophenolic Acid 4Melphalan 4Busulfan 3luspatercept 2Vorinostat 2Thiotepa 2Sirolimus 2Peripheral Blood Stem Cell Transplantation 2Lenalidomide 2Granulocyte Colony-Stimulating Factor 2Biopsy 2Azacitidine 2AP 1903 reagent 2venetoclax 1ribociclib 1palbociclib 1olaparib 1ibrutinib 1hetrombopag 1edoxaban 1decitabine and cedazuridine drug combination 1apixaban 1acalabrutinib 1abemaciclib 1Valganciclovir 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Molecular Diagnostic Techniques × Classical hematology × Clear all
NCT00542373 2026-03-05

Widefield Fluorescence and Reflectance Imaging Systems and Oral Tissue Samples in Monitoring Participants at Risk for Developing Oral Cancer

M.D. Anderson Cancer Center

Phase NA Active not recruiting
338 enrolled
Classical hematologyDermatologicHead & Neck

Erythroplasia, Fanconi Anemia, Lichen Planus, Mouth Neoplasms, Tobacco Use Disorder, Leukokeratosis, Hereditary Mucosal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡